- Summary
- Inspection and licensing of entities authorizing pharmacovigilance market introduction and clinical trials strengthens ANARME's institutional capacity, in addition to promoting the development of AIPROMEM. ANARME and IP are working intensely to reach maturity levels III after complying with 100 of the WHO recommendations. Regarding the tracking and evaluation of medicines, ANARME seeks to reach maturity levels III after complying with 100 of the WHO recommendations. The organization highlights that its training in AIPROMEM allows the country to track and evaluate medicines.
ANARME can reach maturity III after complying with 100 of the WHO recommendations. This objective includes raising awareness about the safety of medicines. To this end, Mozambique reinforces multidisciplinary coordination in the fight against antimicrobial resistance. ANARME is institutionalizing the control of the circulation of drugs in the country to allow monitoring. Furthermore, the IP highlights the significant progress in the regulation of medicines in the country. - Title
- ANARME
- Description
- ANARME
- Keywords
- saber, base, dados, checklists, guies
- NS Lookup
- A 196.13.101.79
- Dates
-
Created 2026-04-11Updated 2026-04-22Summarized 2026-04-21
Query time: 2169 ms